Template:Main Page News: Difference between revisions

From Embryology
mNo edit summary
mNo edit summary
 
(75 intermediate revisions by the same user not shown)
Line 1: Line 1:
{| width=700px|
{| width=800px|
|-bgcolor="CEDFF2"  
|-bgcolor="CEDFF2"  
| <span style="font-size:150%">'''Australia - Gestational Diabetes (2015)'''</span>
| <span style="font-size:150%">'''News - Complete human day 14 post-implantation embryo models from naïve Embryonic Stem Cells'''</span>
|-bgcolor="F5FAFF"  
|-bgcolor="F5FAFF"  
| valign=top| [[File:Australia - insulin-treated diabetes by type 2015.jpg|250px|right|alt=Australia - insulin-treated diabetes by type 2015|link=Australian_Statistics#Incidence_of_insulin-treated_diabetes_in_Australia_2015]]
| valign=top|[[File:Stage6 bf03.jpg|thumb|150px|alt=Carnegie Stage 6 Embryo|Carnegie Stage 6 Embryo]]


'''Proportion of insulin-treated diabetes by type (2015)''' The 2017 published AIHW fact sheet provides the latest available national data on new cases of insulin-treated diabetes in Australia.
This recent Nature paper{{#pmid:37673118|PMID37673118}} describes the use of naïve human Embryonic Stem Cells to recapitulate the early stages of human development.
It shows that in 2015 there were 28,775 people who began using insulin to treat their diabetes in Australia
* 63% had type 2 diabetes
* '''26%''' (18,142) had [[Abnormal Development - Maternal Diabetes|gestational diabetes]]
* 9% had type 1 diabetes
* 2% had other forms of diabetes or their diabetes status was unknown.


In 2015, 7,405 women began using insulin to manage gestational diabetes—130 cases per 100,000 women of reproductive age (15–49 years), or around 1 in every 800 women aged 15–49. This represents almost 1 in 4 (24%) women diagnosed with gestational diabetes aged 15–49 in 2015. Gestational diabetes occurs when higher than normal blood glucose is diagnosed for the first time during pregnancy. It generally occurs in the second or third trimester, among women who have not previously been diagnosed with other forms of diabetes.
"The ability to study human post-implantation development remains limited due to ethical and technical challenges associated with intrauterine development after implantation....only genetically unmodified human naïve human ES cells...recapitulate the organization of nearly all known lineages and compartments of post-implantation human embryos including epiblast, hypoblast, extra-embryonic mesoderm, and trophoblast surrounding the latter layers...These human complete SEMs demonstrated developmental growth dynamics that resemble key hallmarks of post-implantation stage embryogenesis up to 13-14 days post-fertilization (dpf) (Carnegie stage 6a)."


Reference: AIHW 2017. Incidence of insulin-treated diabetes in Australia, 2015. Diabetes series no. 27. Cat. no. CVD 78. Canberra: AIHW. Viewed 20 February 2017 http://www.aihw.gov.au/publication-detail/?id=60129558632.
:'''Links:''' {{stem cells}} | Carnegie stage {{CS6}}


:'''Links:''' [[Abnormal Development - Maternal Diabetes|Maternal Diabetes]] | [http://www.aihw.gov.au/publication-detail/?id=60129558632 AIWH Factsheet]
<references/>
{| class="wikitable mw-collapsible mw-collapsed"
! Older News Articles &nbsp;
|-
|-
|  
| [[Template_talk:Main_Page_News|'''Older News Articles''']] - [[Template_talk:Main_Page_News#January|Climate Change Abnormal Development]] | [[Template_talk:Main_Page_News#December|Air Pollution]] | [[Template_talk:Main_Page_News#February|Rare Sesquizygotic Twinning]] | [[Template_talk:Main_Page_News#June|Australia's mothers and babies 2017]] | [[Template_talk:Main_Page_News#October|Spinal Muscular Atrophy Screening]] | [[Template_talk:Main_Page_News#February|Australian 2018 Pregnancy Care Guidelines]] | [[Template_talk:Main_Page_News#July|CRISPR]] | [[Template_talk:Main_Page_News#June|Ronan O’Rahilly]]
:[[Template_talk:Main_Page_News|'''Older News Articles''']] - [[Template_talk:Main_Page_News#September|Kyoto eBook]] | [[Template_talk:Main_Page_News#August|Dolly's sisters live on!]] | [[Template_talk:Main_Page_News#June|Thalidomide in Zebrafish]] | [[Template_talk:Main_Page_News#March|Human pancreas stem cells]] | [[Template_talk:Main_Page_News#January|Oral contraceptive no risk of major birth defects]] | [[Template_talk:Main_Page_News#September|Maternal Malaria Neurovascular Development Effects]] | [[Template_talk:Main_Page_News#June|Oocyte/Spermatozoa fate decision]] [[Template_talk:Main_Page_News#April|Rubella eliminated in the Americas]] | [[Template_talk:Main_Page_News#February|Three-person embryos]]
|}
|}
|}

Latest revision as of 16:10, 8 September 2023

News - Complete human day 14 post-implantation embryo models from naïve Embryonic Stem Cells
Carnegie Stage 6 Embryo
Carnegie Stage 6 Embryo

This recent Nature paper[1] describes the use of naïve human Embryonic Stem Cells to recapitulate the early stages of human development.

"The ability to study human post-implantation development remains limited due to ethical and technical challenges associated with intrauterine development after implantation....only genetically unmodified human naïve human ES cells...recapitulate the organization of nearly all known lineages and compartments of post-implantation human embryos including epiblast, hypoblast, extra-embryonic mesoderm, and trophoblast surrounding the latter layers...These human complete SEMs demonstrated developmental growth dynamics that resemble key hallmarks of post-implantation stage embryogenesis up to 13-14 days post-fertilization (dpf) (Carnegie stage 6a)."

Links: stem cells | Carnegie stage 6
  1. Oldak B, Wildschutz E, Bondarenko V, Comar MY, Zhao C, Aguilera-Castrejon A, Tarazi S, Viukov S, Pham TXA, Ashouokhi S, Lokshtanov D, Roncato F, Ariel E, Rose M, Livnat N, Shani T, Joubran C, Cohen R, Addadi Y, Chemla M, Kedmi M, Keren-Shaul H, Pasque V, Petropoulos S, Lanner F, Novershtern N & Hanna JH. (2023). Complete human day 14 post-implantation embryo models from naïve ES cells. Nature , , . PMID: 37673118 DOI.
Older News Articles  
Older News Articles - Climate Change Abnormal Development | Air Pollution | Rare Sesquizygotic Twinning | Australia's mothers and babies 2017 | Spinal Muscular Atrophy Screening | Australian 2018 Pregnancy Care Guidelines | CRISPR | Ronan O’Rahilly